Larissa Iceri Perez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Larissa Iceri Perez has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Clóvis Lamartine de Moraes Melo Neto
Department of Dental Materials and Prosthodontics, São Paulo State University (UNESP), School of Dentistry, Araçatuba, São Paulo, Brazil
1 shared publication - Daniela Micheline dos Santos
Department of Dental Materials and Prosthodontics, Aracatuba Dental School, Sao Paulo State University (UNESP), Aracatuba, Sao Paulo, Brazil
1 shared publication - Estéfany Lopes Lemes Do Prado
Department of Dental Materials and Prosthodontics, School of Dentistry, Universidade Estadual Paulista “Júlio de Mesquita Filho” (UNESP), Araçatuba, SP, Brazil
1 shared publication - Fernanda Pereira de Caxias
Department of Health, Prefeitura do Município de Curitiba (PMC), Curitiba, PR, Brazil
1 shared publication - Karina Helga Leal Turcio
Universidade Estadual Paulista, Brasil
1 shared publication - Larissa Viana Pinheiro
Universidade Estadual Paulista, Brasil
1 shared publication
Latest Publications
- Open Access
- 25 January 2026
- Published by Georg Thieme Verlag KG in Brazilian Journal of Oncology
- Vol. 22 (CP)
Sensory Function in Patients with Head and Neck Cancer Undergoing Oncologic Treatment
The treatment of head and neck cancer can significantly impair patients' quality of life, leading to oral and sensorineural complications. This study aimed to explore whether sensory alterations are primarily associated with tumor presence or with the effects of oncologic treatment by longitudinally assessing spontaneous orofacial pain and provoked muscle pain - in a case series of seven patients diagnosed with head and neck cancer undergoing oncologic treatment. Patients were selected from the Oral Oncology Center (COB) of the School of Dentistry at Universidade Estadual Paulista “Júlio de Mesquita Filho”. Assessments were conducted at 5 time points: baseline (T0), 30 to 45 days post-surgery (T1), one-week post-chemotherapy (T2), during radiotherapy (T3), and one-week post-radiotherapy (T4). Sensory function was analyzed through spontaneous pain measured by the Numeric Rating Scale (NRS) from 0 to 10, and provoked pain assessed via palpometry using 1 kg pressure and algometry tests on the masseter, temporalis, and sternocleidomastoid muscles. Only one patient (case 1) reported pain at T0, while two patients (cases 3 and 4) reported pain related to radiotherapy. Provoked muscle pain was highest at T0, particularly in cases 1, 4, and 7, but did not correlate with algometry pain thresholds. This case series indicates that sensory function may be affected by both tumor presence and oncologic treatment in a subset of patients.
- 25 January 2026
- Published by Georg Thieme Verlag KG in Brazilian Journal of Oncology
- Vol. 22 (CP)
Open AccessSensory Function in Patients with Head and Neck Cancer Undergoing Oncologic Treatment
The treatment of head and neck cancer can significantly impair patients' quality of life, leading to oral and sensorineural complications. This study aimed to explore whether sensory alterations are primarily associated with tumor presence or with the effects of oncologic treatment by longitudinally assessing spontaneous orofacial pain and provoked muscle pain - in a case series of seven patients diagnosed with head and neck cancer undergoing oncologic treatment. Patients were selected from the Oral Oncology Center (COB) of the School of Dentistry at Universidade Estadual Paulista “Júlio de Mesquita Filho”. Assessments were conducted at 5 time points: baseline (T0), 30 to 45 days post-surgery (T1), one-week post-chemotherapy (T2), during radiotherapy (T3), and one-week post-radiotherapy (T4). Sensory function was analyzed through spontaneous pain measured by the Numeric Rating Scale (NRS) from 0 to 10, and provoked pain assessed via palpometry using 1 kg pressure and algometry tests on the masseter, temporalis, and sternocleidomastoid muscles. Only one patient (case 1) reported pain at T0, while two patients (cases 3 and 4) reported pain related to radiotherapy. Provoked muscle pain was highest at T0, particularly in cases 1, 4, and 7, but did not correlate with algometry pain thresholds. This case series indicates that sensory function may be affected by both tumor presence and oncologic treatment in a subset of patients.